EDITORIAL
Published on 05 Jun 2024
Editorial: Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
doi 10.3389/fphar.2024.1431975
- 374 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
9,659
Total downloads
28k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 19 Apr 2024
Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis
doi 10.3389/or.2024.1374513
- 1,034 views
- 1 citation
TECHNOLOGY AND CODE
Published on 11 Apr 2024
ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification
doi 10.3389/fphar.2024.1375112
- 853 views
- 1 citation
REVIEW
Published on 08 Mar 2024
Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
doi 10.3389/fphar.2024.1355242
- 3,481 views
- 5 citations
ORIGINAL RESEARCH
Published on 26 Feb 2024
TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi 10.3389/fimmu.2024.1356833
- 2,732 views
ORIGINAL RESEARCH
Published on 16 Jan 2024
A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
doi 10.3389/fphar.2023.1259051
- 2,422 views
- 1 citation
PERSPECTIVE
Published on 18 Dec 2023
Glioblastoma may evade immune surveillance through primary cilia-dependent signaling in an IL-6 dependent manner
doi 10.3389/fonc.2023.1279923
- 2,003 views
- 3 citations
ORIGINAL RESEARCH
Published on 20 Nov 2023
Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas
doi 10.3389/fphar.2023.1276466
- 1,680 views
- 4 citations
ORIGINAL RESEARCH
Published on 08 Nov 2023
Multi-omics analysis reveals CLIC1 as a therapeutic vulnerability of gliomas
doi 10.3389/fphar.2023.1279370
- 1,728 views
- 1 citation
REVIEW
Published on 30 Jun 2023
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
doi 10.3389/fphar.2023.1211719
- 3,566 views
- 11 citations
HYPOTHESIS AND THEORY
Published on 30 May 2023
Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
doi 10.3389/fphar.2023.1156492
- 1,480 views
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 28kTopic views
- 17kArticle views
- 9,659Article downloads